Fig. 4From: Efficacy and safety of baricitinib in treatment of systemic lupus erythematosus: a systematic review and meta-analysisA forest plot displaying the prevalence of Reduction of ≥ 4 points from baseline in Systemic LupusErythematosus Disease Activity Index 2000 score in the baricitinib group versus the placebo groupBack to article page